- MTBC +26% on announcement of the initial launch of MTBC WebSoft.
- MBOT +11% on continue to solidify IP portfolio with US patent for device for preventing shunt stenosis.
- BKD +10% in talks with Zhonghong Zhuoye.
- HRB +9% on Q4 result.
- EKSO +9%.
- INFN +8% on launching XTM II, a next generation packet-optical platform delivering rich Layer.
- RDHL +8% on announced positive top-line results from the Phase III GUARD study with BEKINDA 24 mg for acute gastroenteritis and gastritis.
- ABIL +5%.
- SRNE +6% on acquisition of Glasgow.
- GNMK +6% on pricing public offering of common stock.
- ALXN +5%.
- DFIN +5% on pricing secondary offering.